Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Heine

Showing results (271-280 of 346) with videos related to

Pageof 35
Sort By:
Journal of the American College of Cardiology|January 14, 2017
HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney DiseaseLucie Bauer, Sabine Kern, Kyrill S Rogacev, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2018
Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?Insa E Emrich, Nicolas Vodovar, Linda Feuer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2007
Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patientsMatthias Girndt, Peter Stenvinkel, Christof Ulrich, et al.
Pharmacology Research & Perspectives|June 15, 2021
Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non-dialysis CKD: An observational studyInsa E Emrich, Gunnar H Heine, P Christian Schulze, et al.
Infection and Immunity|December 1, 1992
Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharideA J Ulmer, W Feist, H Heine, et al.
Cor Et Vasa|January 1, 1988
Scientific prognosis of trends in the development of cardiovascular surgery in the socialist countriesV S Chekanov, C Dragoichev, A Arvay, et al.
Progress in Clinical and Biological Research|January 1, 1994
Biological activity of lipid A partial structuresA J Ulmer, H Heine, W Feist, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 27, 2019
Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?Insa E Emrich, Juliane Dederer, Angelika Kircher, et al.
Medicine|November 19, 2016
Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathyJelmer K Humalda, Sarah Seiler-Muler, Arjan J Kwakernaak, et al.
American Journal of Nephrology|May 19, 2016
Best Albuminuria Measurement to Predict Cardiovascular and Renal EventsLucie Bauer, Insa E Emrich, John W Pickering, et al.
Pageof 35

Showing results (271-280 of 346) with videos related to

Sort By:
Pageof 35
Journal of the American College of Cardiology|January 14, 2017
HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney DiseaseLucie Bauer, Sabine Kern, Kyrill S Rogacev, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2018
Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?Insa E Emrich, Nicolas Vodovar, Linda Feuer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2007
Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patientsMatthias Girndt, Peter Stenvinkel, Christof Ulrich, et al.
Pharmacology Research & Perspectives|June 15, 2021
Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non-dialysis CKD: An observational studyInsa E Emrich, Gunnar H Heine, P Christian Schulze, et al.
Infection and Immunity|December 1, 1992
Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharideA J Ulmer, W Feist, H Heine, et al.
Cor Et Vasa|January 1, 1988
Scientific prognosis of trends in the development of cardiovascular surgery in the socialist countriesV S Chekanov, C Dragoichev, A Arvay, et al.
Progress in Clinical and Biological Research|January 1, 1994
Biological activity of lipid A partial structuresA J Ulmer, H Heine, W Feist, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 27, 2019
Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?Insa E Emrich, Juliane Dederer, Angelika Kircher, et al.
Medicine|November 19, 2016
Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathyJelmer K Humalda, Sarah Seiler-Muler, Arjan J Kwakernaak, et al.
American Journal of Nephrology|May 19, 2016
Best Albuminuria Measurement to Predict Cardiovascular and Renal EventsLucie Bauer, Insa E Emrich, John W Pickering, et al.
Pageof 35